Issue Date: June 16, 2008
Invitrogen to Acquire Applied Biosystems
Invitrogen, the biotechnology consumables and services firm, will purchase Applera's Applied Biosystems Group—a supplier of instrument systems, software, and other products to biotech researchers—in a stock and cash transaction valued at $6.7 billion. The combined company, to be called Applied Biosystems, will have annual sales of some $3.5 billion. "This transaction combines the industry's premier consumables provider with the industry's premier systems provider to create a world-class biotechnology tools company," says Gregory T. Lucier, CEO of Invitrogen, who will be become CEO of the new company.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society